# Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer

> **NCT07486492** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital of Xiamen University** · enrollment: 10 (estimated)

## Conditions studied

- Colorectal Cancer Metastatic
- Fecal Microbiota Transplantation

## Interventions

- **DRUG:** yFMT

## Key facts

- **NCT ID:** NCT07486492
- **Lead sponsor:** The First Affiliated Hospital of Xiamen University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-31
- **Primary completion:** 2028-01-31
- **Final completion:** 2028-01-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07486492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07486492, "Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07486492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*